In a Nutshell
At the heart of any powerful technology are countermeasures and precision control. Amit Choudhary believes CRISPR is no exception.
More about Amit
Chemist, biophysicist and professor Amit Choudhary is a renowned pioneer in the development of precision control tools for genome editing using CRISPR-Cas9 in multiple systems, including gene drives. In 2011 Amit was appointed a Junior Fellow of the Harvard Society of Fellows and was hosted by Professor Stuart Schreiber at the Broad Institute where his research focused on beta-cell chemical biology. Amit’s laboratory, The Choudhary Laboratory, now develops chemical technologies and studies exceptional organisms that survive conditions considered pathological to humans. The Choudhary Laboratory has been widely recognized by the Juvenile Diabetes Research Foundation’s Innovation Award, Burroughs Wellcome Fund’s Career Award at the Scientific Interface, NIH Director's Transformative Research Award, DARPA's Safe Genes award, and Vilcek Prize for Creative Promise in Biomedical Sciences. Amit is an Assistant Professor of Medicine at Harvard Medical School, an Associate Biologist at Brigham and Women’s Hospital, and an Associate Member of the Broad Institute of MIT and Harvard.